1
Clinical Trials associated with Kamuvudine-9Evaluation of K9 in Subjects with Thyroid Eye Disease (TED)
The objective of this clinical trial is to evaluate the plasma pharmacokinetics of K9 in healthy subjects (Cohort 1) and the safety and treatment efficacy of K9 in patients with active Thyroid Eye Disease (Cohort 2). Participants will receive study medication one time or for up to 4 weeks. Participants will have blood drawn and/or complete eye exams and questionnaires.
The planned duration of this study is 6 weeks.
100 Clinical Results associated with Kamuvudine-9
100 Translational Medicine associated with Kamuvudine-9
100 Patents (Medical) associated with Kamuvudine-9
100 Deals associated with Kamuvudine-9